Experimental study on the protective effect of Puerarin to Parkinson disease

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 23, Issue 2, 2003, Pages 148-150

  Li, Xueli ^a   Sun, Shenggang ^a   Tong, E'tang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Parkinson disease; Protection; Puerarin

Indexed keywords

APOPTOSIS; ESTROGEN; PARKINSON DISEASE (PD); PUERARIN;

CELLS; COMPLEXATION; ENZYME KINETICS; HISTOLOGY; HORMONES; IMMUNOLOGY; NEUROLOGY; PATIENT TREATMENT;

DISEASES;

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ESTROGEN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN; PLANT MEDICINAL PRODUCT; PUERARIN; TYROSINE 3 MONOOXYGENASE; VASODILATOR AGENT;

ANIMAL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; FEMALE; METABOLISM; MOUSE; OVARIECTOMY; PARKINSON DISEASE; RANDOMIZATION; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; APOPTOSIS; ESTROGENS; FEMALE; ISOFLAVONES; MICE; MICE, INBRED BALB C; OVARIECTOMY; PARKINSON DISEASE; PHYTOESTROGENS; PLANT PREPARATIONS; RANDOM ALLOCATION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VASODILATOR AGENTS;

EID: 3142532464     PISSN: 0257716X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Richard E, Heikkila R E, Hessand R C et al. Dopaminergic neurotoxicity of 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine in mice. Science, 1984,224:1451
2. Arai N, Misugi K, Goshima Y et al. Evaluation of 1-Methyl-4-Phenyl-1,2,3, 6-Tetahydropyridine (MPTP)-treated C57 black mouse model for Parkinsonism. Brain Res, 1990,515(1-2):57
3. Shepherd J E. Effects of estrogen on congnition, mood, and degenerative brain diseases. J Am Pharm Assoc (Wash), 2001,41(2):221
4. Patisaul H B, Dindo M, Whitten P L et al. Soy isoflavone supplements antagonize reproductive behavior and estrogen receptor alpha- and beta-dependent gene expression in the brain. Endocrinology, 2001,142(7):2946
5. Cyr M, Calon F, Morissette M et al. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr Pharm Des, 2000,6(12):1287
6. Knight D C, Eden A. A review of the clinical effects of phyto-estrogens. Obstetrics Ggnecology, 1996,87(5):897
7. Sawada H, Shimobama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neuron. Neurosci Biobehav Rev, 2000,24(1):143
8. Sawada H, Ibi M, Kihara T et al. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res, 1998,54 (5):707
9. Sawada H, Ibi M, Kihara T et al. Mechanisms of anti-apoptotic effects of estrogens in dopaminergic neurons. FASEB J, 2000,14(9):1202